• MRSA Extracellular Vesicles and OSCC IL-8 Signaling

  2026-10-03

  A 2026 study reports that extracellular vesicles from methicillin-resistant Staphylococcus aureus can promote oral squamous cell carcinoma through an IL-8–CXCR1 signaling axis. Its main contribution is linking antibiotic-resistant bacteria, vesicle-mediated cargo delivery, ERK/c-Jun activation, and tumor-cell proliferation while identifying IL-8 loss and CXCR1 blockade as mechanistic tests.

• Sorafenib in Liver Cancer: Kinase–Metabolic Readouts

  2026-10-01

  Sorafenib (BAY-43-9006) is more than a standard multikinase inhibitor: it can serve as a mechanistic benchmark for separating RAF/MEK/ERK, angiogenic, and organelle-stress readouts. This article connects Sorafenib assay design with recent evidence on mitochondrial cholesterol metabolism in hepatocellular carcinoma models.

• Rimonabant (SR141716) in CB1 Withdrawal Research

  2026-10-01

  Rimonabant (SR141716) turns CB1 pharmacology into a practical challenge assay for withdrawal, appetite, inflammation, and cell-signaling studies. This guide pairs sex-aware behavioral design with formulation, dosing, and troubleshooting decisions that improve mechanistic resolution.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-09-30

  Cy7 NHS ester (SKU A8109) is a sulfonated, water-soluble amino-group labeling reagent for proteins, peptides, and related biomolecules when an aqueous workflow is preferred. This guide covers preparation, conjugation, purification, and QC for near-infrared imaging; it does not establish cellular uptake, in vivo performance, or assay suitability without application-specific validation.

• Trelagliptin Succinate Research Workflows

  2026-09-30

  Trelagliptin succinate, also known as SYR-472 succinate, supports reproducible DPP-4 enzyme inhibition studies alongside cell, animal, and pharmaceutical quality workflows. This guide combines practical dosing design, stability-aware handling, validated HPLC concepts, and troubleshooting for diabetes mellitus research.

• Cediranib (AZD2171) In Vitro Research Workflows

  2026-09-29

  Cediranib (AZD2171) is a potent, orally bioavailable angiogenesis inhibitor for dissecting VEGFR signaling, endothelial responses, and tumor-associated pathway biology. This workflow emphasizes matched pathway, proliferation, and cell-death measurements so a reduced viability signal is not mistaken for a single biological mechanism.

• NHS-Biotin: Practical Protein Labeling Workflow

  2026-09-29

  NHS-Biotin provides an amine-reactive route for attaching biotin to antibodies, proteins, and other primary amine-containing biomolecules for streptavidin-based detection or purification. It is suited to irreversible labeling workflows, but not to experiments requiring site-specific control, reversible labeling, or unverified intracellular performance.

• ZDHHC4 Palmitoylation Limits TRPV1 Nociception

  2026-09-28

  A 2025 EMBO Reports study identifies ZDHHC4-mediated S-palmitoylation as a mechanism that reduces TRPV1 abundance through lysosomal degradation, helping resolve inflammatory pain. The work also places APT1-dependent depalmitoylation in a counter-regulatory position, linking lipid modification, channel turnover, and nociceptive recovery.

• SIRT1-Dependent Mitochondrial Biogenesis in Prion Stress

  2026-09-28

  Zhao et al. report that SIRT1 overexpression or activation mitigates PrP106–126-associated mitochondrial damage in N2a cells, with the PGC-1α–TFAM pathway implicated in restoring mitochondrial biogenesis. The study links these mitochondrial effects to reduced cellular apoptosis and offers a mechanistic framework for testing SIRT1-directed interventions in prion-stress models, while leaving important questions about disease relevance and mechanism specificity open.

• MK0787 Against Resistant Bacteria: A 1982 Comparison

  2026-09-27

  This 1982 study compared N-formimidoyl thienamycin (MK0787) with several β-lactam antibiotics across clinical isolates, including resistant Gram-negative bacteria, Pseudomonas, Acinetobacter, and oxacillin-resistant staphylococci. Its main contribution is a broad comparative susceptibility and bactericidal assessment; Cefazedone (Refosporen) was one of the comparators, although the headline findings do not establish it as the leading agent.

• Sulfo-Cy3 NHS Ester for Reliable Cell Assays

  2026-09-26

  Learn how Sulfo-Cy3 NHS ester (SKU A8107) can support fluorescent protein and peptide labeling alongside cell viability, proliferation, or cytotoxicity studies. This scenario-driven guide explains its spectral and solubility specifications, practical handling, experimental limits, and product-selection considerations.

• Recombinant Human IL-6 in Cell-Based Assays

  2026-09-25

  Recombinant Human IL-6, Tag Free is considered here as a defined cytokine reagent—not as a mechanism established in blastoid research. Using a recent WDR36 study as a case study, this article explains how to separate metabolic lineage evidence from exploratory cytokine experiments.

• Sulfo-Cy3 NHS Ester for Vascular Assay Design

  2026-09-25

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for studying protein interactions and endothelial remodeling. This article connects its labeling chemistry to practical assay decisions for separating molecular association, uptake, and vascular cell-fate outcomes.

• (+)-Bicuculline: Practical Assay Workflow

  2026-09-24

  (+)-Bicuculline is a competitive GABAA receptor antagonist used to investigate inhibitory synaptic transmission and related neuronal signaling. This guide covers preparation and assay controls for research use only; the compound is not intended for diagnostic, therapeutic, or clinical applications.

• SIRT7 Limits AKT/mTOR-Linked Periodontal Cell Senescence

  2026-09-24

  The study reports that SIRT7 overexpression reduces Porphyromonas gingivalis LPS-associated senescence markers, inflammatory cytokines, and AKT/mTOR phosphorylation in human periodontal ligament fibroblasts, while SIRT7 knockdown produces opposing effects. These findings position SIRT7 as a candidate regulator of inflammatory damage in this cell model, while leaving its precise molecular targets and relevance in whole-organism periodontitis to be tested.

8553 records 1/571 page Next 12345 下5页 Last page